Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 53% of Pharmacists Consider iHerb a Serious Competitor

Tuesday, July 28, 2020

49% of pharmacists see the growing iHerb service as an absolute danger, because more and more people buy OTC drugs online, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. However, it is obvious that the respondents also meant other online marketplaces, since the Russian market has a number of specialized and non-specialized players selling dietary supplements, cosmetic products, and other pharmacy products. Another 4% of the pharmacists note that the consumer is basically the same both online and offline, and their budget is very limited due to the current economic conditions.

As many as 35% of the respondents are not afraid of such competition, believing that the product selection still has significant differences, and delivery requires time, sometimes quite a lot. Another 9% are sure that there is no need to be afraid of serious competition as long as the online sale of Rx drugs is banned in Russia.

2% of the respondents – not only regular pharmacists, but also heads of pharmacies and pharmacy chains – have never even heard of iHerb. Some of them are aged between 25 and 35.

Do you see the iHerb service, which is growing in Russia, as a potential danger and competitor? (single-answer question)